Antipodes Partners’s Brookdale Senior Living BKD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$178M Sell
11,091,757
-315,057
-3% -$4.28M 3.27% 7
2026
Q1
$156M Sell
11,406,814
-22,020
-0.2% -$309K 3% 9
2025
Q4
$123M Sell
11,428,834
-666,835
-6% -$6.56M 2.59% 14
2025
Q3
$102M Sell
12,095,669
-2,056,104
-15% -$15.7M 2.3% 19
2025
Q2
$98.5M Buy
14,151,773
+467,273
+3% +$3.04M 3.06% 14
2025
Q1
$85.7M Buy
13,684,500
+6,124,238
+81% +$32.8M 2.68% 17
2024
Q4
$38M Buy
7,560,262
+3,507,044
+87% +$20.1M 1.32% 28
2024
Q3
$27.5M Buy
4,053,218
+4,038,548
+27,529% +$28.8M 0.95% 34
2024
Q2
$100K Buy
+14,670
New +$99.2K ﹤0.01% 56

Other funds holding BKD

Antipodes Partners's BKD Position: Q2 2026 in Review

Antipodes Partners reduced its Brookdale Senior Living (BKD) stake by 2.8% in Q2 2026, selling an estimated $4.28M and leaving 11,091,757 shares worth $178M. The position accounts for 3.27% of the portfolio, ranked #7.

Antipodes Partners first reported a position in BKD in Q2 2024 and has held it in 9 quarters since. 292 funds tracked by Wall St. Rank hold BKD as of Q2 2026.

  • Antipodes Partners held 11,091,757 shares of Brookdale Senior Living worth $178M as of Q2 2026.
  • Antipodes Partners sold 315,057 Brookdale Senior Living shares in Q2 2026, an estimated $4.28M.
  • Brookdale Senior Living made up 3.27% of Antipodes Partners's portfolio in Q2 2026, its #7 holding.
  • Antipodes Partners first reported a position in Brookdale Senior Living in Q2 2024 and has held it in 9 quarters since.
  • 292 funds tracked by Wall St. Rank held Brookdale Senior Living as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.